Frontiers in Pharmacology | Respiratory Pharmacology

Perspective

Published on 09 Mar 2023

Current possibilities and future opportunities provided by three-dimensional lung ECM-derived hydrogels

in Respiratory Pharmacology

Mehmet Nizamoglu
Janette K. Burgess

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154193

3,363 views
7 citations

Original Research

Published on 09 Mar 2023

Sex-specific non-linear associations between body mass index and impaired pulmonary ventilation function in a community-based population: Longgang COPD study

in Respiratory Pharmacology

Hao Huang
Xueliang Huang
Jiaman Liao
Yushao Li
Yaoting Su
Yaxian Meng
Yiqiang Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1103573

2,995 views
2 citations

Original Research

Published on 09 Mar 2023

Urolithin A (UA) attenuates ferroptosis in LPS-induced acute lung injury in mice by upregulating Keap1-Nrf2/HO-1 signaling pathway

in Respiratory Pharmacology

Lejing Lou
Min Wang
Jingjing He
Song Yang
Fanxi Meng
Shijia Wang
Xiao Jin
Jihao Cai
Chang Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1067402

14,654 views
39 citations

Original Research

Published on 06 Mar 2023

A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip

in Respiratory Pharmacology

Arunima Sengupta
Aurélien Dorn
Mohammad Jamshidi
Magali Schwob
Widad Hassan
Lea Lara De Maddalena
Andreas Hugi
Andreas O. Stucki
Patrick Dorn
Thomas M. Marti

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1114739

11,367 views
26 citations

Clinical Trial

Published on 27 Feb 2023

Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers

in Respiratory Pharmacology

Qian Dong
Hongmei Qiao
Huiyi Jiang
Lixiao Liu
Yanling Ge
Fang-Jiao Zong
Yanan Li
Bingzi Dong
Sujuan Hu
Dongmei Meng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1094089

3,228 views

Review

Published on 14 Feb 2023

Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Xudan Yang
Zhihao Xu
Songhua Hu
Juan Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1111393

8,341 views
12 citations

Review

Published on 13 Feb 2023

What is the need and why is it time for innovative models for understanding lung repair and regeneration?

in Respiratory Pharmacology

Daniel J. Weiss

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130074

3,580 views
3 citations

Original Research

Published on 10 Feb 2023

Ferroptosis-related genes are involved in asthma and regulate the immune microenvironment

in Respiratory Pharmacology

Haixia Wang
Yuanmin Jia
Junlian Gu
Ou Chen
Shouwei Yue

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1087557

9,099 views
19 citations

Original Research

Published on 03 Feb 2023

Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis

in Respiratory Pharmacology

Huimin Ji
Hongliang Dong
Yuejiao Lan
Yuqian Bi
Xuan Gu
Yongyue Han
Chongyang Yang
Minghan Cheng
Jian Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1089812

5,089 views
11 citations

Original Research

Published on 30 Jan 2023

Long-term clinical course and outcomes of patients with microscopic polyangiitis-associated interstitial lung disease

in Respiratory Pharmacology

Min Jee Kim
Donghee Lee
Jooae Choe
Jin Woo Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1064307

3,115 views
6 citations

Clinical Trial

Published on 19 Jan 2023

Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial

in Respiratory Pharmacology

Jiande Chen
Qiuyu Tang
Baoqin Zhang
Shuhua Yuan
Jia Chen
Shiyu Shen
Dong Wang
Jilei Lin
Hongliang Dong
Yong Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1092748

2,871 views
5 citations

Editorial

Published on 16 Jan 2023

Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems

in Respiratory Pharmacology

Yasuhiko Koga
Yosuke Kamide
Takeshi Hisada
Tamotsu Ishizuka

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1037610

1,605 views

Mini Review

Published on 13 Jan 2023

Open questions in human lung organoid research

in Respiratory Pharmacology

Tessa Hughes
Krijn K. Dijkstra
Emma L. Rawlins
Robert E. Hynds

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1083017

7,054 views
9 citations

Original Research

Published on 12 Jan 2023

Fast cycling of intermittent hypoxia in a physiomimetic 3D environment: A novel tool for the study of the parenchymal effects of sleep apnea

in Respiratory Pharmacology

Alicia Jurado
Anna Ulldemolins
Helena Lluís
Xavier Gasull
Núria Gavara
Raimon Sunyer
Jorge Otero
David Gozal
Isaac Almendros
Ramon Farré

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1081345

2,420 views

Original Research

Published on 09 Jan 2023

Dang Gui Bu Xue Tang, a conventional Chinese herb decoction, ameliorates radiation-induced heart disease via Nrf2/HMGB1 pathway

in Respiratory Pharmacology

Yifan Huang
Minghan Cheng
Xiaoye Wang
Hongliang Dong
Jian Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1086206

3,632 views
8 citations

Original Research

Published on 06 Jan 2023

Tetramethylpyrazine ameliorates acute lung injury by regulating the Rac1/LIMK1 signaling pathway

in Respiratory Pharmacology

Simin Min
Weiting Tao
Dushan Ding
Xiaonan Zhang
Shidi Zhao
Yong Zhang
Xiaojie Liu
Kefei Gao
Saisai Liu
Li Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1005014

4,197 views
14 citations